Back to Journals » Drug Design, Development and Therapy » Volume 9
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Differential benefit risk assessment of DOACs in the treatment of venous thromboembolism: focus on dabigatran
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
18,820 | Dovepress* | 16,132+ | 1,732 | 17,864 | |
PubMed Central* | 2,688 | 761 | 3,449 | ||
Totals | 18,820 | 2,493 | 21,313 | ||
*Since 9 July 2015 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
4 | 1 | 0 | 0 | 1 | 2 |
View citations on PubMed and Google Scholar